Investigating protein structure and aggregation related to Alzheimer's disease using advanced spectroscopy
Probing protein structure and aggregation in complex environments with 2D IR spectroscopy
This study is exploring new ways to look at proteins involved in Alzheimer's disease to better understand how they change and clump together, which could help find new treatments for the condition.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Vanderbilt University NIH-funded |
| Lab location | 1 site (Nashville, UNITED STATES) |
| Project ID | NIH-10940937 on NIH RePORTER |
What this research studies
This research aims to develop innovative spectroscopic techniques to better understand protein structures and their interactions in complex biological environments, particularly focusing on Alzheimer's disease. By utilizing two-dimensional infrared (2D IR) spectroscopy, the researchers will study how proteins like the Alzheimer's β-amyloid change and aggregate in conditions that are typically difficult to analyze. The approach involves using unnatural amino acids to gain insights into protein dynamics and interactions, which could lead to a deeper understanding of the mechanisms behind Alzheimer's pathology. This research could ultimately contribute to identifying new therapeutic targets or strategies for managing Alzheimer's disease.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at risk for or diagnosed with Alzheimer's disease, particularly those with early-stage symptoms.
Not a fit: Patients with other forms of dementia unrelated to Alzheimer's may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to breakthroughs in understanding Alzheimer's disease, potentially paving the way for new treatments.
How similar studies have performed: Previous research has shown promise in using advanced spectroscopic methods to study protein interactions, indicating that this approach could yield valuable insights.
Where this research is happening
Nashville, UNITED STATES
- Vanderbilt University — Nashville, United States (Active)
Researchers
- Principal investigator: Buchanan, Lauren E — Vanderbilt University
- Study coordinator: Buchanan, Lauren E
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.